No Association Between Statin Use and the Prognosis of Endometrial Cancer in Women With Type 2 Diabetes
Preclinical studies have suggested statins have antiproliferative and anti-metastatic effects on endometrial cancer cells. Similarly, most previous epidemiological studies have reported a better prognosis of endometrial cancer in patients who used statins. In this study, we explored the role of stat...
Main Authors: | Elina Urpilainen, Anne Ahtikoski, Reetta Arima, Ulla Puistola, Peeter Karihtala |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.621180/full |
Similar Items
-
Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study
by: Elina Urpilainen, et al.
Published: (2018-07-01) -
Metformin, statins and the risk and prognosis of endometrial cancer in women with type 2 diabetes
by: Arima, R. (Reetta)
Published: (2019) -
Statin use and the risk of ovarian and endometrial cancers: a meta-analysis
by: Yizi Wang, et al.
Published: (2019-07-01) -
Statin use and prognosis of lung cancer: a systematic review and meta-analysis of observational studies and randomized controlled trials
by: Xia DK, et al.
Published: (2019-01-01) -
Identification of an eleven-miRNA signature to predict the prognosis of endometrial cancer
by: Jing Lu, et al.
Published: (2021-01-01)